ReviewCancer chemotherapy and pharmacology2024

Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations.

Chukwunonso K NwabufoPubMed ↗Publisher ↗

No numbers read from the abstract.